Fig. 6From: Computational and pharmacokinetics studies of 1,3-dimethylbenzimidazolinone analogues of new proposed agent against Alzheimer's diseaseA and B showed the 3D and 2D docking interactions between ligand 21 and receptor, respectivelyBack to article page